Crinetics Pharmaceuticals (CRNX) Assets Growth (3y) (2020 - 2026)
Crinetics Pharmaceuticals (CRNX) Assets Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - |
| 10 | Crinetics Pharmaceuticals | 8.74 Bn | 7.44 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.64% |
| Dec 31, 2025 | 47.33% |
| Sep 30, 2025 | 45.93% |
| Jun 30, 2025 | 45.15% |
| Mar 31, 2025 | 59.85% |
| Dec 31, 2024 | 59.88% |
| Sep 30, 2024 | 64.82% |
| Jun 30, 2024 | 62.77% |
| Mar 31, 2024 | 81.52% |
| Dec 31, 2023 | 51.30% |
| Sep 30, 2023 | 47.40% |
| Jun 30, 2023 | 10.54% |
| Mar 31, 2023 | 36.35% |
| Dec 31, 2022 | 39.27% |
| Sep 30, 2022 | 39.26% |
| Jun 30, 2022 | 39.56% |
| Mar 31, 2022 | 25.96% |
| Dec 31, 2021 | 26.99% |
| Sep 30, 2021 | 5.82% |
| Jun 30, 2021 | 42.67% |